The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis

Figure 1

Overall survival (OS) for 1016 patients according to the response to the first-line therapy who at least achieved PR and who were below PR.